IMPAIRED EXPRESSION OF THE PROTEINS MGMT AND EZRIN IN ENDOMETRIAL HYPERPLASIA, ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA, AND LOW-GRADE ENDOMETRIOID ADENOCARCINOMA IN PERIMENOPAUSAL WOMEN


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. To study the impaired expression of the proteins 0-6-methylguanine-DNA methyltransferase (MGMT) and ezrin in different forms of endometrial hyperplasia (EH), endometrial intraepithelial neoplasia (EIN), and low-grade endometrioid adenocarcinoma (EAC) in perimenopausal women. Subjects and methods. Thirty-five perimenopausal patients, including 12 with simple EH (SHE) without atypia (Group 1), 9 with complex EH (CEH) without atypia (Group 2), 5 with CEH with atypia (CEHA) (Group 3), 5 with EIN (Group 4), and 4 with low-grade EAC (Group 5), which were histologically and immunohistochemically verified using Ki67 and PTEN, were examined. Nine removed uteri and 22 endometrial scrapes were explored. The results of an immunohistochemical examination of ezrin expression and data on the level of MGMT protein expression in endometrial tissues were presented. Results. The level of MGMTprotein expression increases in SHE and CEH, peaks at the stages of CEHA and EIN, and decreases in EAC. The specific features of ezrin expression are associated with that, as the disease progresses from simple HE to EAC, there is a loss of its apical specific localization, as well as free cell cytoplasmic accumulation. Conclusion. The obtained results of clinicoanamnestic, diagnostic, and immunohistochemical studies in the above patient groups can substantiate a differentiated approach to choosing a treatment policy for patients with different forms of EH.

全文:

受限制的访问

作者简介

Yevgeniya Kogan

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University

Email: e_koganevg@oparina4.ru
MD, Professor, head of the 1st Pathology Department Moscow 117997, Ac. Oparina str. 4, Russia; Moscow 119991, Trubetskaya str. 8, Russia

Svetlana Askolskaya

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: askolskayas@mail.ru
MD, leading researcher at the Department of General Surgery Moscow 117997, Ac. Oparina str. 4, Russia

Rauanna Sagindykova

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: sagindykova.r@mail.ru
postgraduate, 1st Pathology Department Moscow 117997, Ac. Oparina str. 4, Russia

Nafisa Fayzullina

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: nafisa05@inbox.ru
Senior Researcher, 1st Pathology Department Moscow 117997, Ac. Oparina str. 4, Russia

Alexandra Asaturova

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Senior Researcher, 1st Pathology Department Moscow 117997, Ac. Oparina str. 4, Russia

Ara Unanjan

I.M. Sechenov First Moscow State Medical University

Email: unan@yandex.ru
PhD Moscow 119991, Trubetskaya str. 8, Russia

参考

  1. Wright T.C., Holinka C.F., Ferenczy A., Gatsonis C.A., Mutter G.L., Nicosia S., Richart R.M. Estradiol-induced hyperplasia in endometrial biopsies from women on hormone replacement therapy. Am. J. Surg. Pathol. 2002; 26(10): 1269-75.
  2. Trimble C.L., Kauderer J., Zaino R., Silverberg S., Lim P.C., Burke J.J. 2nd. et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006; 106(4): 812-9.
  3. Kurosawa H., Ito K, Nikura H., Takano T., Nagase S., Utsunomiya H. et al. Hysteroscopic inspection and total curettage are insufficient for discriminating endometrial cancer from atypical endometrial hyperplasia. Tohoku J. Exp. Med. 2012; 228(4): 365-70.
  4. Mutter C.L. Endometrial intraepithelial neoplasia (EIN): Will it bring order to chaos? The Endometrial Collaborative Group. Gynecol. Oncol. 2000. 76: 287-90.
  5. Власов P.C., Карпов Д.В., Залетаев Д.В., Коган Е.А, Демура Т.А., Макарова И.И., Гуриев Т.Д., Идрисова Э.А., Богуш О.С., Бадгоева О.Х., Сидорова И.С., Унанян А.Л. Метилирование генов-супрессоров опухолевого роста при патологических процессах эндометрия. Проблемы репродукции. 2010; Специальный выпуск (IV международный конгресс по репродуктивной медицине): 285-6.
  6. Пальцев М.А., Залетаев Д.В., ред. Система генетических и эпигенетических маркеров в диагностике онкологических заболеваний. М.: Медицина; 2009. 384 с.
  7. Станоевич И.В., Землякова В.В., Фен И., Аброкова Б.С., Залетаев Д.В. Аномальное метилирование ряда генов при гиперплазии эндометрия на фоне хронического эндометрита. Российский вестник акушера-гинеколога. 2012; 1: 21-2.
  8. Ikeda S., Imura J., Suzuki K. Protein expression, mRNA expression and gene amplification of DNA methyltransferase 1 in endometrial tumor tissues. Mol. Clin. Oncol. 2013; 1(3): 423-9.
  9. Patra S.K., Bettuzzi S. Epigenetic DNA-methylation regulation of genes coding for lipid raft-associated components: A role for raft proteins in cell transformation and cancer progression (review). Oncol. Rep. 2007; 17(6): 1279-90.
  10. Сидорова И.С., Унанян А.Л., Власов Р.С., Залетаев Д.В., Киселев В.Н., Евтина И.П., Карпов Д.В., Кадырова А.Э. Клиническое значение аномального метилирования генов-супрессоров опухолевого роста при патологических процессах эндометрия и шейки матки. Врач. 2011; 1: 21-3.
  11. Bugni J.M., Han J., Tsai M.S., Hunter D.J., Samson L.D. Genetic association and functional studies of major polymorphic variants of MGMT. DNA Repair (Amst). 2007; 6(8): 1116-26.
  12. Tan O., Ornek T., Fadiel A., Carrick K.S., Arici A., Doody K., Carr B.R., Naftolin F.G. Expression and activation of the membrane-cytoskeleton protein ezrin during the normal endometrial cycle. Fertil. Steril. 2012; 97(1): 192-9.
  13. Slater M., Cooper M., Murphy C.R. The cytoskeletal proteins alpha-actinin, ezrin, and talin are de-expressed in endometriosis and endometrioid carcinoma compared with normal uterine epithelium. Appl. Immunohistochem. Mol. Morphol. 2007; 15(2): 170-4.
  14. Ohtani K., Sakamoto H., Rutherford T., Chen Z., Kikuchi A., Yamamoto T. et al. Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma. Cancer lett. 2002; 179(1): 79-86.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##